| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Feb―18 |
New thiosemicarbazones possessing activity against SARS-CoV-2 and H1N1 influenza viruses |
Olga A. Zhupikova, Olga Ivanovna Yarovaya, Mariya K. Marenina, Yulia V. Meshkova, Svetlana V. Belenkaya, Dmitriy N. Shcherbakov, et al. (+11) Anna V. Zaykovskaya, Oleg V. Pyankov, Vladimir V. Zarubaev, Mikhail G. Mikhalsky, Alexey Yu. Fedorov, Sergey G. Arkhipov, Vladimir Ivanovich Potkin, Irina A. Kolesnik, Andrey Viktorovich Ivanov, Nariman Faridovich Salakhutdinov, Mikhail V. Khvostov |
| 2 |
[GO] |
2024―Aug―09 |
Synthesis of pseudocyclic peptide of protein S of SARS-CoV-2 and its interaction with diagnostically significant antibodies of COVID-19 patients |
Ivan M. Ryzhov, Polina S. Obukhova, Oxana E. Galanina, Eugenia M. Rapoport, Natalia S. Egorova, Nicolai V. Bovin, Alexander B. Tuzikov |
| 3 |
[GO] |
2023―Jul―17 |
New N1-(4-aryloxybenzyl)uracils containing N3-positioned 4-(trimethyleneoxy)benzoic acid moiety, and study of their antiviral activity against SARS-CoV-2 and influenza virus |
Mikhail S. Novikov, Maria P. Paramonova, Ilia M. Kirillov, Olga A. Smirnova, Anastasia L. Khandazhinskaya, Alexander O. Chizhov, et al. (+3) Sergey N. Kochetkov, Alexander V. Ivanov, Irina F. Fedyakina |
| 4 |
[GO] |
2022―May―27 |
Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations |
Chuanming Zhang, Chao Zhang, Yanli Meng, Tai Li, Zhe Jin, Shicheng Hou, Chun Hu |
| 5 |
[GO] |
2020―Aug―04 |
Computational identification of disulfiram and neratinib as putative SARS-CoV-2 main protease inhibitors |
Victor S. Stroylov, Igor V. Svitanko |
|
